MeSH D007383 - intermittent claudication
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cilostazol | Cilostazol | 2005-03-01 | |||
| Rising Pharmaceuticals | Cilostazol | Cilostazol | 2006-04-20 | |||
| Apotex | Cilostazol | Cilostazol | 2004-12-10 | |||
| Chartwell Pharmaceuticals | Cilostazol | Cilostazol | 2012-09-24 | |||
| Nostrum Laboratories | Cilostazol | Cilostazol | 2009-09-28 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
40%2/5
Phase 2
40%4/10
Phase 3
29%4/14
Approved: 2Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use